BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 9788619)

  • 21. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.
    Reber L; Da Silva CA; Frossard N
    Eur J Pharmacol; 2006 Mar; 533(1-3):327-40. PubMed ID: 16483568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
    Samayawardhena LA; Hu J; Stein PL; Craig AW
    Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.
    Litz J; Sakuntala Warshamana-Greene G; Sulanke G; Lipson KE; Krystal GW
    Lung Cancer; 2004 Dec; 46(3):283-91. PubMed ID: 15541812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor.
    Gao Y; Tang S; Zhou S; Ware JA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):426-33. PubMed ID: 11160627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
    Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
    Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
    Rapecki S; Allen R
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling.
    Warshamana-Greene GS; Litz J; Buchdunger E; Hofmann F; García-Echeverría C; Krystal GW
    Mol Cancer Ther; 2004 May; 3(5):527-35. PubMed ID: 15141010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
    Mekori YA; Oh CK; Metcalfe DD
    J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells.
    Shivakrupa R; Linnekin D
    Cell Signal; 2005 Jan; 17(1):103-9. PubMed ID: 15451030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene.
    Sekido Y; Takahashi T; Ueda R; Takahashi M; Suzuki H; Nishida K; Tsukamoto T; Hida T; Shimokata K; Zsebo KM
    Cancer Res; 1993 Apr; 53(7):1709-14. PubMed ID: 7680956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Yes tyrosine kinase activity in human colon carcinoma.
    Park J; Meisler AI; Cartwright CA
    Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.
    Arcaro A; Aubert M; Espinosa del Hierro ME; Khanzada UK; Angelidou S; Tetley TD; Bittermann AG; Frame MC; Seckl MJ
    Cell Signal; 2007 May; 19(5):1081-92. PubMed ID: 17275257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
    Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
    Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
    Yamaguchi H; Hendrickson WA
    Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
    Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G
    Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells.
    Pignata C; Prasad KV; Hallek M; Druker B; Rudd CE; Robertson MJ; Ritz J
    Cell Immunol; 1995 Oct; 165(2):211-6. PubMed ID: 7553885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling.
    Kazi JU; Vaapil M; Agarwal S; Bracco E; Påhlman S; Rönnstrand L
    Cell Signal; 2013 Sep; 25(9):1852-60. PubMed ID: 23707526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation and serine phosphorylation of the p56lck protein tyrosine kinase in response to antigen receptor cross-linking in B lymphocytes.
    Gold MR; Chiu R; Ingham RJ; Saxton TM; van Oostveen I; Watts JD; Affolter M; Aebersold R
    J Immunol; 1994 Sep; 153(6):2369-80. PubMed ID: 8077654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.